Information  X 
Enter a valid email address

Dr. Martens PLC (DOCS)

  Print   

Wednesday 10 February, 2021

Dr. Martens PLC

Director/PDMR Shareholding

RNS Number : 5310O
Dr. Martens PLC
10 February 2021
 

Director/PDMR Shareholding

Notification of Transactions by Directors/Persons Discharging Managerial Responsibility

Dr. Martens plc (the "Company") announces that on 9 February 2021 the following directors / persons discharging managerial responsibility ('PDMRs') were granted Performance Share Awards (the "Awards") under the Company's Long Term Incentive Plan (the "LTIP") over ordinary shares of the Company (the "Shares").

PDMR

Number of Shares

Kenny Wilson

567,567

Jon Mortimore

364,864

 

As previously disclosed in the Company's final prospectus dated 29 January 2021, the Awards will vest subject to the achievement of challenging earnings per share (67% weighting) and relative total shareholder return (33% weighting) targets over three years and, on vesting, will be subject to a further two-year holding period.

No consideration was paid for the grant of the Awards and no price is payable on the exercise of the Awards.

The relevant notifications set out below are provided in accordance with the requirements of Article 19 of the Market Abuse Regulation.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Kenny Wilson

2

Reason for the notification

a)

Position/status

PDMR (Chief Executive Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Grant of performance share award under the Dr. Martens Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0

567,567 shares

d)

Aggregated information

-

Aggregated volume

-

Price

 

567,567 shares

 

£0

e)

Date of the transaction

9 February 2021

f)

Place of the transaction

Outside a trading venue

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Jon Mortimore

2

Reason for the notification

a)

Position/status

PDMR (Chief Financial Officer)

b)

Initial notification/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Dr. Martens plc

b)

LEI

213800QPT8YM6NQZPH28

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of GBP 0.01

 

ISIN: GB00BL6NGV24

b)

Nature of the transaction

Grant of performance share award under the Dr. Martens Long Term Incentive Plan

c)

Price(s) and volume(s)

Price(s)

Volume(s)

£0

364,864 shares

d)

Aggregated information

-

Aggregated volume

-

Price

 

364,864 shares

 

£0

 

 

e)

Date of the transaction

9 February 2021

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUKSBRABUURAR

a d v e r t i s e m e n t